Study evaluating the efficacy of combination therapy of intravitreal ranibizumab and photodynamic therapy in patients with symptomatic retinal angiomatous proliferation.
Phase of Trial: Phase IV
Latest Information Update: 29 Nov 2016
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 29 Nov 2016 New trial record